Top Buy
| Security | Buy | Sell | Buy (1W) ▼ | Sell (1W) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Biogen Inc. | 49 | 1 | 2 | 0 | €199.25 | €293.57 | 47.339% |
| Abbott Laboratories | 17 | 0 | 1 | 0 | €93.34 | €116.71 | 25.041% |
| Vertex Pharmaceuticals Inc. | 47 | 2 | 1 | 0 | €410.85 | €425.79 | 3.636% |
| Amgen Inc. | 25 | 0 | 0 | 0 | €275.55 | €297.31 | 7.898% |
| AbbVie Inc. | 22 | 0 | 0 | 0 | €141.52 | €175.11 | 23.736% |
| Eli Lilly Corp. | 49 | 0 | 0 | 0 | €736.70 | €786.51 | 6.761% |
| Merck & Co. Inc. | 28 | 1 | 0 | 0 | €116.00 | €124.92 | 7.692% |
| Pfizer Inc. | 27 | 4 | 0 | 0 | €25.92 | €40.66 | 56.865% |
| Zoetis Inc. A | 23 | 1 | 0 | 0 | €156.40 | €200.06 | 27.914% |
| Incyte Corp. | 12 | 2 | 0 | 0 | €52.24 | €78.42 | 50.119% |
| Regeneron Pharmaceuticals Inc. | 36 | 1 | 0 | 0 | €892.00 | €958.32 | 7.435% |